Medicine
Ciprofloxacin 250 mg tablet
Ciprofloxacin 250 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Ciprofloxacin
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 20 tablets, 30 tablets and 196 more
- Manufacturers
- Aurobindo PharmaIndiaBryant Ranch PrepackChartwell RXCarlsbad TechnologyPharmPakYiling PharmaceuticalAmneal Pharmaceuticals NYMethod PharmaceuticalsRising Pharma HoldingsSolco Healthcare28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA02 Ciprofloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 June 2004
- Identifiers
- RxCUI 197511, 309309, 197512DailyMed set ID d358eb18-f4d0-e9ba-e053-2a95a90a435d, 2efbda2a-fc97-b7c5-e063-6294a90a362d, 3b3c0874-90b7-deda-e063-6394a90a7802 +37NDC 72189-304, 72189-616, 72789-519 +37Application ANDA076558, ANDA208921, ANDA077859 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 199 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 59651-866-01 | Aurobindo PharmaIndia | 9 February 2024 |
| 100 tablet, film coated in 1 bottle | 59651-976-01 | Aurobindo PharmaIndia | 27 March 2025 |
| 20 tablet, film coated in 1 bottle | 59651-976-20 | Aurobindo PharmaIndia | 27 March 2025 |
| 30 tablet, film coated in 1 bottle | 59651-976-30 | Aurobindo PharmaIndia | 27 March 2025 |
| 1000 tablet, film coated in 1 bottle | 59651-976-99 | Aurobindo PharmaIndia | 27 March 2025 |
| 100 tablet, film coated in 1 bottle | 65862-076-01 | Aurobindo PharmaIndia | 26 April 2007 |
| 100 tablet, film coated in 1 bottle | 69238-2432-1 | Amneal Pharmaceuticals NY | 29 February 2024 |
| 100 tablet, film coated in 1 bottle | 61442-222-01 | Carlsbad Technology | 10 October 2009 |
| 1000 tablet, film coated in 1 bottle | 61442-222-10 | Carlsbad Technology | 10 October 2009 |
| 100 tablet, film coated in 1 bottle, plastic | 62135-308-01 | Chartwell RX | 13 April 2021 |
| 20 tablet, film coated in 1 bottle, plastic | 62135-308-20 | Chartwell RX | 13 April 2021 |
| 28 tablet, film coated in 1 bottle, plastic | 62135-308-28 | Chartwell RX | 13 April 2021 |
| 100 tablet, coated in 1 bottle | 58657-675-01 | Method Pharmaceuticals | 12 August 2020 |
| 1 bottle in 1 box / 6 tablet in 1 bottle | 54348-662-06 | PharmPak | 10 July 2019 |
| 1 bottle in 1 box / 14 tablet in 1 bottle | 54348-662-14 | PharmPak | 10 July 2019 |
| 100 tablet, film coated in 1 bottle | 16571-411-10 | Rising Pharma Holdings | 10 September 2004 |
| 100 tablet in 1 bottle | 43547-688-10 | Solco Healthcare | 1 October 2023 |
| 100 tablet in 1 bottle | 85293-002-01 | Umasuto | 5 March 2025 |
| 100 tablet, coated in 1 bottle | 69117-0008-1 | Yiling Pharmaceutical | 13 July 2019 |
| 500 tablet, coated in 1 bottle | 69117-0008-2 | Yiling Pharmaceutical | 13 July 2019 |
| 7 tablet in 1 bottle | 71335-0408-0 | Bryant Ranch Prepack | 4 May 2022 |
| 20 tablet in 1 bottle | 71335-0408-1 | Bryant Ranch Prepack | 4 May 2022 |
| 10 tablet in 1 bottle | 71335-0408-2 | Bryant Ranch Prepack | 4 May 2022 |
| 14 tablet in 1 bottle | 71335-0408-3 | Bryant Ranch Prepack | 4 May 2022 |
| 6 tablet in 1 bottle | 71335-0408-4 | Bryant Ranch Prepack | 4 May 2022 |
| 30 tablet in 1 bottle | 71335-0408-5 | Bryant Ranch Prepack | 4 May 2022 |
| 60 tablet in 1 bottle | 71335-0408-6 | Bryant Ranch Prepack | 4 May 2022 |
| 12 tablet in 1 bottle | 71335-0408-7 | Bryant Ranch Prepack | 4 May 2022 |
| 40 tablet in 1 bottle | 71335-0408-8 | Bryant Ranch Prepack | 4 May 2022 |
| 90 tablet in 1 bottle | 71335-0408-9 | Bryant Ranch Prepack | 4 May 2022 |
| 7 tablet, coated in 1 bottle | 71335-1152-0 | Bryant Ranch Prepack | 29 January 2025 |
| 20 tablet, coated in 1 bottle | 71335-1152-1 | Bryant Ranch Prepack | 29 January 2025 |
| 10 tablet, coated in 1 bottle | 71335-1152-2 | Bryant Ranch Prepack | 29 January 2025 |
| 14 tablet, coated in 1 bottle | 71335-1152-3 | Bryant Ranch Prepack | 29 January 2025 |
| 6 tablet, coated in 1 bottle | 71335-1152-4 | Bryant Ranch Prepack | 29 January 2025 |
| 30 tablet, coated in 1 bottle | 71335-1152-5 | Bryant Ranch Prepack | 29 January 2025 |
| 60 tablet, coated in 1 bottle | 71335-1152-6 | Bryant Ranch Prepack | 29 January 2025 |
| 12 tablet, coated in 1 bottle | 71335-1152-7 | Bryant Ranch Prepack | 29 January 2025 |
| 40 tablet, coated in 1 bottle | 71335-1152-8 | Bryant Ranch Prepack | 29 January 2025 |
| 90 tablet, coated in 1 bottle | 71335-1152-9 | Bryant Ranch Prepack | 29 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 October 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ciprofloxacin 250 mg tablet.
Other strengths and forms of Ciprofloxacin
Clinical summary
Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated, among other approved uses. MedsAcross supplies Ciprofloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CiprofloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cipro prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Ciprofloxacin 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.